U.S. Solid Tumor Testing Market Advances as Thermo Fisher Scientific Expands Precision Oncology, with Global Market Rising from USD 32.9 billion in 2026 to USD 65.9 billion by 2036 at a 7.2% CAGR ROCKVILLE, MARYLAND , August 24, 2026 — The global solid tumor testing market reached a valuation of USD 30.7 billion in 2025. Demand is projected to expand from USD...